Glycine ameliorates liver injury and vitamin D deficiency induced by bile duct ligation

Clinica Chimica Acta

Volumn 420, Issue , 2013, Pages 150-154

  Chen, Chiung Yu ^a   Wang, Bei Tzu ^a   Wu, Zih Ciang ^a   Yu, Wen Ting ^a   Lin, Po Ju ^a   Tsai, Wei Lun ^b   Shiesh, Shu Chu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

25 Hydroxyvitamin D; Bile duct ligation; Glycine

Indexed keywords

25 HYDROXYERGOCALCIFEROL; ALANINE; ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIFEDIOL; CASPASE 3; GLYCINE; MALONALDEHYDE; SERINE; TYROSINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GUINEA PIG; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ANIMALS; BILE DUCTS; GLYCINE; GLYCINE AGENTS; GUINEA PIGS; LIGATION; LIVER; MALE; OXIDATIVE STRESS; TANDEM MASS SPECTROMETRY; VITAMIN D; VITAMIN D DEFICIENCY;

ANIMALIA; CAVIA;

EID: 84877619059     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.016     Document Type: Article

References (35)

1. Trauner M., Meier P.J., Boyer J.L. Molecular pathogenesis of cholestasis. N Engl J Med 1998, 339:1217-1227.
2. Greim H., Trulzsch D., Roboz J., et al. Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology 1972, 63:837-845.
3. Patel T., Bronk S.F., Gores G.J. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994, 94:2183-2192.
4. Kwo P., Patel T., Bronk S.F., Gores G.J. Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. Am J Physiol 1995, 268:G613-G621.
5. Ryter S.W., Kim H.P., Hoetzel A., et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007, 9:49-89.
6. Marsh D.C., Vreugdenhil P.K., Mack V.E., Belzer F.O., Southard J.H. Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress. Hepatology 1993, 17:91.
7. Nichols J.C., Bronk S.F., Mellgren R.L., Gores G.J. Inhibition of nonlysosomal calcium- dependent proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology 1994, 106:168.
8. Zhong Z., Jones S., Thurman R.G. Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol 1996, 270:G332.
9. Zhong Z.H.I., Connor H.D., Yin M., et al. Dietary glycine and renal denervation prevents cyclosporine A-induced hydroxyl radical production in rat kidney. Mol Pharmacol 1999, 56:455-463.
10. Schemmer P., Bradford B.U., Rose M.L., et al. Intravenous glycine improves survival in rat liver transplantation. Am J Physiol 1999, 276:G924.
11. Mauriz J.L., Matilla B., Culebras J.M., Gonzalez P., Gonzalez-Gallego J. Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat. Free Radic Biol Med 2001, 31:1236-1244.
12. El Hafidi M., Pe'rez I., Banos G. Is glycine against elevated blood pressure?. Curr Opin Clin Nutr Metab Care 2006, 9:26-31.
13. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
14. Bolt M.J., Sitrin M.D., Favus M.J., Rosenberg I.H. Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salts. Hepatology 1981, 1:436-440.
15. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80:1678S-1688S.
16. Holick M.F. Vitamin D, deficiency. N Engl J Med 2007, 357:266-281.
17. Petta S., Camma C., Scazzone C., et al. Low vitamin D serum concentration is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010, 51:1158-1167.
18. Targher G., Bertolini L., Scala L., et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007, 17:517-524.
19. Zhang A., Wang Y., Xie H., Zheng S. Calcitriol inhibits hepatocyte apoptosis in rat allograft by regulating apoptosis-associated genes. Int Immunopharmacol 2007, 7:1122-1128.
20. Canbay A., Higuchi H., Bronk S.F., Taniai M., Sebo T.J., Gores G.J. Fas enhances fibrogenesis in the bile duct-ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002, 123:1323-1330.
21. Witek R.P., Stone W.C., Karaca F.G., et al. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 2009, 50:1421-1430.
22. Anraku M., Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res 2001, 18:632-639.
23. Bhagavan N.V., Lai E.M., Rios P.A., et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003, 49:581-585.
24. Jalan R., Schnurr K., Mookerjee R.P., et al. Alteration in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology 2009, 50:555-564.
25. Chen C.Y., Tsai W.L., Lin P.J., Shiesh S.C. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clin Chem Lab Med 2011, 49:1817-1821.
26. Maunsell Z., Wright D.J., Rainbow S.J. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005, 51:1683-1690.
27. Shiesh S.C., Chen C.Y., Lin X.Z., Liu Z.A., Tsao H.C. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology 2000, 32(3):455-460.
28. Heubi J.E., Hollis B.W., Specker B., Tsang R.C. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 1989, 9:258-264.
29. Plourde V., Gascon-Barre M., Willems B., Huet P.M. Severe cholestasis leads to vitamin D depletion without perturbing its C-25 hydroxylation in the dog. Hepatology 1988, 8:1577-1585.
30. Sheth H., Hafez T., Glantzounis G.K., Seifalian A.M., Fuller B., Davidson B.R. Glycine maintains mitochondrial activity and bile composition following warm liver ischemia-reperfusion injury. J Gastroenterol Hepatol 2011, 26:194-200.
31. Gutierrez J.A., Parikh N., Branch A.D. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis 2011, 31:387-398.
32. Nakano T., Cheng Y.F., Lai C.Y., et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011, 55:415-425.
33. Rahman A.H., Branch A.D. Vitamin D for your patients with chronic hepatitis C?. J Hepatol 2012, 10.1016/j.jhep.2012.07.026.
34. Weinberg J.M., Varani J., Johnson K.J., et al. Protection of human umbilical vein endothelial cells by glycine and structurally similar amino acids against calcium and hydrogen peroxide-induced lethal cell injury. Am J Pathol 1992, 140:457-471.
35. Fedirko V., Bositick R.M., Long Q., et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010, 19:280-291.